SABR plus surgery is effective for treating lung cancer
Combining neoadjuvant stereotactic ablative radiotherapy (SABR) with surgery...Read more on AuntMinnie.comRelated Reading: Lung cancer imaging on the upswing in China AI uses features outside nodules to predict malignancy Global lung screening project shows early promise ASTRO: SABR is effective for oligometastatic cancers Australia tries new rad therapy approach for secondary lung cancers
ConclusionPLN metastasis was a quite common pattern of LN metastasis in N1 station of NSCLC. IPLNM occurred more frequently in central NSCLC and NSCLC with vascular invasion, and thoracotomy was likely to secure more accurate PLN staging. Clinicians should pay great attention to PLN dissection. Follow ‐up data will be needed in order to detect the prognosis of IPLNM patients.
Conditions: Non-small Cell Lung Cancer; Hepatocellular Carcinoma Interventions: Drug: Nivolumab; Drug: BMS-813160; Drug: BMS-986253 Sponsors: Icahn School of Medicine at Mount Sinai; Bristol-Myers Squibb Not yet recruiting
Condition: Stage III Non-small-cell Lung Cancer Interventions: Other: Neoadjuvant therapy; Other: Chemotherapy concurrent with radiotherapy; Radiation: Radiotherapy; Drug: Nivolumab; Other: Observation Sponsor: Sun Yat-sen University Not yet recruiting